About Elira
Elira is a Healthcare company based in St. Louis (United States) founded in 2004. Wearable neurostimulation devices for appetite suppression are developed by Elira. Elira has raised $8.63 million across 7 funding rounds. Its focus areas include Life Sciences, Obesity, Medical Devices and Therapeutic Devices. Its competitors include EnteroMedics, Aspire Bariatrics and Endosphere; 3 of its 3 listed competitors have raised funding.
Company details
Elira was founded in 2004 in St. Louis, United States, and operates in the health technology sector. A wearable patch called ELIRA 2, based on neurostimulation, is being developed to influence eating habits through appetite suppression. The companys focus remains on creating non-invasive devices aimed at managing dietary behaviors, with operations centered in the U.S. market.
- Total Equity Funding$8.63M (USD)
in 7 rounds
- Latest Funding Round$1.25M (USD), Series A
Dec 2022
Funding Insights of Elira
Elira has successfully raised a total of $8.63M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.25 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.63M
- Total Rounds 7
- Last Round Series A — $1.25M
- First Round $1.1M
(Sep 2015)
All 7 funding rounds of Elira with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $1.25M | Series A | – | – | – |
| Jan 2021 | $1.57M | Series A | – | – | – |
| Nov 2019 | $973,729 | Seed | – | – | – |
| Mar 2019 | $912,662 | Seed | – | – | – |
| Aug 2018 | $923,093 | Seed | – | – | – |
| Dec 2016 | $1.9M | Seed | – | – | – |
| Sep 2015 | $1.1M | Seed | – | – | – |
Timeline of Elira
3 dated milestones of Elira across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Elira is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A, of $1.3M.
Competitors of Elira
Elira has 3 listed competitors in our database, 3 of them funded. They include EnteroMedics, Aspire Bariatrics and Endosphere.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enteromedics.com | 2002 | Saint Paul, United States | $62.1M | 63 | Satiety induction through vagal nerve block | |
| aspirebariatrics.com | 2004 | King Of Prussia, United States | $29.44M | 7 | Aspire Bariatrics is focused on weight loss solutions. | |
| endosphereinc.com | 2006 | Columbus, United States | $6.45M | Provides a duodenal insertable implant for effective obesity treatment. |
Detailed competitors of Elira
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Obesity
3 companies that operate in the same segment as Elira (Obesity) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elira
Elira was founded in 2004 and raised its 1st funding round 11 years after it was founded.
Elira is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Elira is a funded company, having raised a total of $8.63M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.1M, raised on Sep 2015.
Elira was founded in 2004 in St. Louis, United States, and operates in the health technology sector. A wearable patch called ELIRA 2, based on neurostimulation, is being developed to influence eating habits through appetite suppression. The companys focus remains on creating non-invasive devices aimed at managing dietary behaviors, with operations centered in the U.S. market.
Elira's top competitors include EnteroMedics, Aspire Bariatrics and Endosphere.